Global Health Care on Cardano

Why is it important?

Currently Big Pharma controls manufacturing, pricing, and global access to life-saving medications and devices. Decentralization is needed.

What does success look like?

Proposals for projects that use Cardano to decentralize: development, production, access to drugs & tech to combat critical global illnesses

Key Metrics to measure

Number of proposals that address a critical global illness such as Cancer, Autoimmune Diseases, Diabetes, Malaria, Dengue/TB, Coronavirus, Heart Disease and others
Number of proposals that democratize, decentralize, or broaden access to life-saving or life-improving drugs and devices
Number of proposals that focus on improving health care outside of the geographies currently housing the headquarters of big pharma companies

Challenge brief

As Mahatma Gandhi has said, “It is health that is the real wealth, and not pieces of gold and silver.” Sadly, although longevity and physical well-being have increased for some, big pharma’s control over critical medications can result in significant struggles for those in other parts of the globe .

As just one example, currently just three pharmaceutical companies, Eli Lilly, Novo Nordisk, and Sanofi, manufacture the insulin, which 7.5 million diabetics must inject in order to stay alive. https://www.newyorker.com/magazine/2020/05/25/the-rogue-experimenters The Open Insulin Foundation (<https://openinsulin.org/>) serves as one inspiration for this challenge. The group is “creating the means for communities in-need to have local sources of safe, affordable, high-quality insulin…governance is shared between people with diabetes and people working on the project.”

Cardano offers enormous potential to build on or replicate this model, by offering the capacity for globally decentralized coordination and governance. The blockchain provides the perfect means to transfer power from centralized corporations to the people at the edges.

This challenge is looking for projects that will boost Cardano’s profile and spur adoption in the developing, among the global medical and pharmaceutical communities, and, most importantly, will offer hope and opportunity to the world-wide suffers of critical and devastating diseases and ailments.

Some directions projects can take:

· Blockchain improvements for global supply chains

· Decentralized or “citizen-science” approaches to research and development

· DAOs for the management of research, manufacturing, or distribution projects

· Decentralized identity (Atala PRISM) solutions for:

Access to healthcare services
Protection of sensitive data
Monetization of data for research such that the data owners benefit
Supply chain tracking
Access and control of medical records
Improve processes and remove costs for health insurance providers

· Blockchain solutions for cost-reduction initiatives in hospitals or care centers

· Blockchain-based standardization for health-care administration to reduce waste

· Solutions for interoperability, locally and globally, for health care records in order to promote accessibility and reduce costs

“He who has health has hope, and he who has hope has everything” Thomas Carlyle

<https://www.youtube.com/embed/0VdEFWq1P0I>

bookmarked!